VetApp

In Europe 235M of pets go to the vet. Over 100M of those visits every year is unnecessary. 
VetApp is a medical application that can identify all those cases and reduce over 30% stress, anxiety and expenses connected to unnecessary visits. 

Problem/opportunity
The European veterinary market is valued at over $32B, growing at a CAGR of 8.8%. The sector faces major challenges: a shortage of veterinary professionals, long appointment wait times, high consultation costs, and the lack of decision-support tools. Up to 35% of in-person vet visits could be unnecessary, while pet owners struggle to access trustworthy me

Solution/product
VetApp’s smart mobile application leverages proprietary AI to conduct guided medical interviews (triage), suggest potential conditions and next steps, offer teleconsultations, and manage health records in the cloud. The prototype version 2.0 recognizes over 800 diseases and processes more than 8,300 symptoms. VetApp is also available as a white-label or API solution for integration into partner ecosystems.

Competitive advantage
VetApp uniquely combines clinical expertise, artificial intelligence, and cloud technology to deliver a next-gen diagnostic and consultation tool. The founding team includes experienced medical professionals, AI engineers, and entrepreneurs with track records in building clinic networks and launching AI-based medical platforms. Its competitive edge lies in lowering care costs by up to 35%, providing scalable B2B integrations, and generating real-time behavioral and medical data valuable for insurers and pet tech partners

Traction
VetApp has over 17 000 users. It is engaged in research collaboration with the University of Berlin on AI-driven animal triage systems. Version 1.2 is already deployed in the market. Company signed the agreement with Europ Assistance that will bring 50 000 paid users to the system. VetApp generates structured medical and behavioral data, enabling customized product offerings, especially for insurance and employee benefit brokers.